WEE1 tyrosine kinase, a novel epigenetic modifier

Area of Science:

• Cell Biology
• Molecular Biology
• Epigenetics

Background:

• Cell cycle progression requires coordinated duplication of DNA, histones, and chromatin, with epigenetic marks being maintained.
• The WEE1 kinase is a known regulator of S phase, ensuring DNA replication completion before mitosis.
• Histone synthesis regulation is crucial for cell cycle control, but its molecular mechanisms are not fully understood.

Purpose of the Study:

• To investigate the role of WEE1 kinase in regulating histone synthesis during the cell cycle.
• To elucidate the molecular mechanism by which WEE1 influences histone gene transcription.
• To explore the implications of WEE1's function in linking epigenetics and cell cycle progression for cancer therapy.

Main Methods:

• Phosphorylation assays to detect WEE1 kinase activity on histone H2B.
• Analysis of histone gene cluster nucleosomes and their associated epigenetic marks.
• Quantitative assessment of histone mRNA levels in relation to WEE1 activity.
• Cell cycle progression analysis in the presence and absence of WEE1 modulation.

Main Results:

• WEE1 kinase phosphorylates histone H2B at tyrosine 37 in nucleosomes upstream of the histone gene cluster.
• This phosphorylation event suppresses histone transcription during late S phase.
• WEE1 kinase acts as a dual regulator, controlling both mitotic entry and chromatin synthesis.

Conclusions:

• WEE1 kinase plays a critical role in coordinating cell cycle progression with histone synthesis through epigenetic regulation.
• The findings establish a direct link between WEE1-mediated epigenetics and cell cycle control.
• Targeting WEE1 kinase presents a potential strategy for developing novel epigenetic inhibitors against cancers with high WEE1 expression.